Format

Send to

Choose Destination
Eur J Pharmacol. 1992 Mar 31;213(3):343-9.

Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures.

Author information

1
Division of Neurology, Childrens Hospital Los Angeles, CA 90027.

Abstract

Experimental absence seizures are characterized by the fact that they are exacerbated by both direct and indirect GABA agonists. To date most of the studies that have examined this phenomenon have utilized GABAA agonists. We assessed the effect of a GABAB agonist, baclofen and a specific GABAB antagonist in two pharmacological models of absence seizures in rodent after using either gamma-hydroxybutyrate or pentylenetetrazole to induce the bilaterally synchronous spike wave discharges that typify absence seizures in rodent. Baclofen markedly prolonged and the GABAB antagonist attenuated or blocked the experimental absence seizures in both models. These data suggest a role for GABAB-related mechanisms in the pathogenesis of generalized absence seizures and raise the possibility that GABAB antagonists may have therapeutic potential as antiabsence drugs.

PMID:
1319918
DOI:
10.1016/0014-2999(92)90623-c
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center